POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 1 filers reported holding POSEIDA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $101,993 | +35.2% | 42,854 | 0.0% | 0.01% | +28.6% |
Q2 2023 | $75,424 | -42.9% | 42,854 | 0.0% | 0.01% | -41.7% |
Q1 2023 | $131,991 | -41.9% | 42,854 | 0.0% | 0.01% | -47.8% |
Q4 2022 | $227,126 | +24.1% | 42,854 | -17.4% | 0.02% | +15.0% |
Q3 2022 | $183,000 | +18.8% | 51,854 | -13.1% | 0.02% | +25.0% |
Q2 2022 | $154,000 | -40.1% | 59,659 | +3.8% | 0.02% | -33.3% |
Q1 2022 | $257,000 | -46.7% | 57,469 | -13.2% | 0.02% | -51.0% |
Q3 2021 | $482,000 | +31.0% | 66,185 | +80.1% | 0.05% | +28.9% |
Q2 2021 | $368,000 | +4.8% | 36,754 | 0.0% | 0.04% | -5.0% |
Q1 2021 | $351,000 | -13.8% | 36,754 | -19.8% | 0.04% | -25.9% |
Q3 2020 | $407,000 | – | 45,833 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 2,945,948 | $5,184,868 | 1.60% |
Aisling Capital Management LP | 1,043,267 | $1,836,150 | 0.90% |
Knott David M Jr | 140,921 | $248 | 0.10% |
XTX Topco Ltd | 233,493 | $410,948 | 0.07% |
Pentwater Capital Management LP | 5,975,000 | $10,516,000 | 0.07% |
Atom Investors LP | 49,413 | $86,967 | 0.03% |
EcoR1 Capital, LLC | 676,296 | $1,190,281 | 0.03% |
Forefront Analytics, LLC | 26,619 | $46,850 | 0.03% |
FNY Investment Advisers, LLC | 11,500 | $20 | 0.02% |
CORNERCAP INVESTMENT COUNSEL INC | 80,979 | $142,523 | 0.02% |